These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3330012)

  • 1. Possible relationships between in vivo antitumour activity and toxicity of tumour necrosis factor-alpha.
    Palladino MA; Patton JS; Figari IS; Shalaby MR
    Ciba Found Symp; 1987; 131():21-38. PubMed ID: 3330012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumour effects of tumour necrosis factor: cytotoxic or necrotizing activity and its mechanism.
    Haranaka K; Satomi N; Sakurai A; Haranaka R
    Ciba Found Symp; 1987; 131():140-53. PubMed ID: 3450479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disparate effects of tumor necrosis factor-alpha/cachectin and tumor necrosis factor-beta/lymphotoxin on hematopoietic growth factor production and neutrophil adhesion molecule expression by cultured human endothelial cells.
    Broudy VC; Harlan JM; Adamson JW
    J Immunol; 1987 Jun; 138(12):4298-302. PubMed ID: 3495589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of tumour necrosis factor in the tumour-necrotizing activity of agents with diverging toxicity.
    van de Wiel PA; van der Pijl A; Bloksma N
    Cancer Immunol Immunother; 1991; 33(2):115-20. PubMed ID: 2036659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of antitumour activity of human recombinant tumour necrosis factor-alpha, alone or in combination with melphalan in a nude mouse human melanoma xenograft system.
    Furrer M; Altermatt HJ; Ris HB; Althaus U; Rüegg C; Liénard D; Lejeune FJ
    Melanoma Res; 1997 Aug; 7 Suppl 2():S43-9. PubMed ID: 9578416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-function relationship of tumour necrosis factor and its mechanism of action.
    Fiers W; Brouckaert P; Goldberg AL; Kettelhut I; Suffys P; Tavernier J; Vanhaesebroeck B; Van Roy F
    Ciba Found Symp; 1987; 131():109-23. PubMed ID: 3131072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of weight loss induced by recombinant tumour necrosis factor with that produced by a cachexia-inducing tumour.
    Mahony SM; Beck SA; Tisdale MJ
    Br J Cancer; 1988 Apr; 57(4):385-9. PubMed ID: 3390373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined treatment of IL-1 alpha and TNF-alpha potentiates the antitumour effect of hyperthermia.
    Lin JC; Park HJ; Song CW
    Int J Hyperthermia; 1996; 12(3):335-44. PubMed ID: 9044903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TNF: its potential as an antitumour agent.
    Fiers W; Beyaert R; Brouckaert P; Everaerdt B; Haegeman C; Suffys P; Tavernier J; Vanhaesebroeck B
    Dev Biol Stand; 1988; 69():143-51. PubMed ID: 3224763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of intraperitoneal recombinant interleukin-1 beta in intraperitoneal human ovarian cancer xenograft models: comparison with the effects of tumour necrosis factor.
    Malik ST; East N; Boraschi D; Balkwill FR
    Br J Cancer; 1992 May; 65(5):661-6. PubMed ID: 1586593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumour necrosis factor-alpha (TNF-alpha) transgene-expressing dendritic cells (DCs) undergo augmented cellular maturation and induce more robust T-cell activation and anti-tumour immunity than DCs generated in recombinant TNF-alpha.
    Zhang W; Chen Z; Li F; Kamencic H; Juurlink B; Gordon JR; Xiang J
    Immunology; 2003 Feb; 108(2):177-88. PubMed ID: 12562326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of small tumour necrosis factor-alpha peptides on tumour cell cytotoxicity, neutrophil activation and endothelial cell procoagulant activity.
    Rathjen DA; Ferrante A; Aston R
    Immunology; 1993 Oct; 80(2):293-9. PubMed ID: 8262557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of dermal and subcutaneous inflammation by recombinant cachectin/tumor necrosis factor (TNF alpha) in the mouse.
    Sharpe RJ; Margolis RJ; Askari M; Amento EP; Granstein RD
    J Invest Dermatol; 1988 Oct; 91(4):353-7. PubMed ID: 3171214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of cytokines on polymorphonuclear neutrophil infiltration in the mouse. Prostaglandin- and leukotriene-independent induction of infiltration by IL-1 and tumor necrosis factor.
    Sayers TJ; Wiltrout TA; Bull CA; Denn AC; Pilaro AM; Lokesh B
    J Immunol; 1988 Sep; 141(5):1670-7. PubMed ID: 3261759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in the bioactivity of recombinant human TNF, LT, and T-cell-derived LT-3 on transformed cells in vitro and the Meth A tumor growing in BALB/c mice.
    Granger GA; Masunaka I; Averbook B; Kobayashi M; Fitzgerald M; Yamamoto R
    J Biol Response Mod; 1988 Oct; 7(5):488-97. PubMed ID: 3263472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in the biological activity of TNF alpha and TNF beta correlate with their different abilities for binding to the target cells.
    Kircheis R; Milleck J; Korobko VG; Shingarova LN; Schmidt HE
    Eur Cytokine Netw; 1992; 3(4):381-90. PubMed ID: 1330049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in endogenous cytokines, adhesion molecules and platelets during cytokine-induced tumour necrosis.
    de Kossodo S; Moore R; Gschmeissner S; East N; Upton C; Balkwill FR
    Br J Cancer; 1995 Nov; 72(5):1165-72. PubMed ID: 7577463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Possible mechanisms for tumour cell sensitivity to TNF-alpha and potential therapeutic applications.
    Obrador E; Carretero J; Pellicer JA; Estrela JM
    Curr Pharm Biotechnol; 2001 Jun; 2(2):119-30. PubMed ID: 11480417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of tumour necrosis factor and related cytokines on vascular endothelial cells.
    Pober JS
    Ciba Found Symp; 1987; 131():170-84. PubMed ID: 3330009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of tumor necrosis factor and interleukin 1 in gamma-interferon-promoted activation of mouse tumoricidal macrophages.
    Hori K; Mihich E; Ehrke MJ
    Cancer Res; 1989 May; 49(10):2606-14. PubMed ID: 2496917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.